medigraphic.com
Órgano Oficial de la Asociación Mexicana de Infectología Pediátrica y la SLIPE.

2013, Number 105

<< Back Next >>

Rev Enfer Infec Pediatr 2013; 26.27 (105)

Extracto del documento del consenso de la Sociedad Española de Infectología Pediátrica (SEIP) y del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP) para la vacunación en niños con inmunodeficiencias primarias

Mellado PMJ

Language: Spanish
References: 12
Page: 322-326
PDF size: 297.07 Kb.


Text Extraction

No abstract


REFERENCES

  1. Al-Sukaiti N, Reid B, Lavi S, Al-Zaharani D, Atkinson A, Roifman CM, et al. Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge síndrome. J Allergy Clin Immunol. 2010;(126):868-869.

  2. Kusuhara K, Ohga S, Hoshina T, Saito M, Sasaki Y, Ishimura M, et al. Disseminated Bacillus Calmette-Guérin lymphadenitis in a patient with gp91phox- chronic granulomatous disease 25 years after vaccination. Eur J Pediatr. 2009;(168): 745-747.

  3. National Health and Medical Research Council. Australian Government. Groups with special vaccination requirements. In: The Australian Immunisation Handbook 9th Edition. Last update: July 2009. Disponible en: http://www.immunise.health.gov.au (ultimo acceso: 20 diciembre 2010).

  4. American Academy of Pediatrics, Committee on Infectious Diseases. Immunization in Special Clinical Circumstances. Immunocompromised children 2009 Report, Red Book 28th ed. Elk Grove Village, IL, USA. p.72-86.

  5. Siber GR, Werner BG, Halsey NA, Reid R, Almeido-Hill J, Garrett SC, et al. Interference of immune globulin with measles and rubella immunization. J Pediatr. 1993; (122):204-211.

  6. Comité Asesor de Vacunas de la Asociación Española de Pediatría. Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2011. An Pediatr. 2011.

  7. Orthopoulos GV, Theodoridou MC, Ladis VA, Tsousis DK, Spoulou VI. The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with beta-thalassemia. Vaccines. 2009;(27): 350-354.

  8. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices. Prevention of pneumococcal disease among infants and children – Use of 13-valent pneumococcal vaccine and 23-valent pneumococcal polysaccharide vaccine. Morb Mortal Wkly Rep. 2010; 59(R-11):1-18.

  9. Price V, Blanchette V, Ford-Jones E. The prevention and management of infections in children with asplenia. Infect Dis Clin N Am. 2007;(21): 697-710.

  10. Health Protection Agency. Guidance on minimising infection in patients with an absent or dysfunctional spleen. Last update: 22 October 2009. Disponible en: http://www.hpa.org.uk (ultimo acceso: 06 diciembre 2010).

  11. Langley JM, Dodds L, Fell D, Langley GR. Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study 1990-2002. BMC Infect Dis. 2010;(10):219.

  12. Patel NC, Hertel PM, Estes MK, De la Morena M, Petru AM, Noroski LM, et al. Vaccine-adquired rotavirus in infants with severe combined inmunodeficiency. N Engl J Med 2010;(362): 314-319.




2020     |     www.medigraphic.com